DPI Research Published a New Report on China In Vitro Diagnostics Market

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

New Delhi, Delhi, December 20, 2016 /India PRwire/ -- The in-vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high-end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.

Long-term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021.

China IVD Market: Segment wise Outlook

Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.

China IVD Market: Companies wise Outlook

Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi-auto and automatic biochemistry analyzers to low and mid-end market users.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.

This report titled "China In Vitro Diagnostics(IVD) - Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021" has been analyzed from 10 viewpoints:

1. Market and Forecast (2010 - 2021)

2. Segment Wise Market and Forecast (2010 - 2021)

3. Company Wise IVD Sales and Forecast (2010 - 2021)

4. Regulation and its Latest Development

5. Future Prospects in Attractive In Vitro Diagnostics Segments

6. Regional Trends and Opportunities

7. Main Participants/Contributors

8. Major IVD Product Companies Outlook

9. Major Private Clinical Labs and Diagnostic Services Companies Outlook

10.Market Growth Drivers and Challenges

The following segments of the China In Vitro Diagnostics market are detailed with size and six year forecast.

Clinical Chemistry

Immunoassay

Molecular Testing

Self-Monitoring of Blood Glucose (SMBG)

Point of Care Testing (POCT)

Hematology

Coagulation

Microbiology

The following companies of the China In Vitro Diagnostics market are detailed with size and six year forecast

Roche Diagnostics

Abbott Laboratories

Mindray Medical International Limited

Sysmex Corporation

Shanghai Kehua Bio-Engineering Co. Ltd.

Other Companies

The following Chinese companies of the China In Vitro Diagnostics market are detailed with company overview and its product portfolio

Mindray Medical International Limited

Shanghai Fosun Pharmaceutical Group

Mingyuan Medicare

Da An Gene Co. Ltd.

Shanghai Kehua Bio-Engineering Co. Ltd.

Zhejiang D.a. Diagnostics Technology Co., Ltd

ADICON Clinical Laboratories

Guangzhou Kingmed Diagnostics Center Co. Ltd.

Kindstar Global

BGI - Shenzhen

OriGene Technologies

Notes to Editor

DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs. DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making. DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


DPI Research & Marketing Solutions recent press release(s)


Hawaii MCI Tourism Market Will Reach 1.3 Billion by 2022

DPI Market Research published a latest report titled"Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 - 2022" to its databases

$ 4 Billion Non Invasive Prenatal Testing Market: Global Demand, Growth Potential & Opportunity Outlook 2017 - 2021

DPI Research has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, Competitive Strategies and Forecasts, 2017 To 2021" report to their offering.

Global Epilepsy Drug Market to Reach USD 5.5 Billion by 2021

DPI Research has announced the addition of the "Epilepsy Drug Market & Forecast to 2021" report to its offering

United States Insulin Pump Market to Reach USD 4 Billion by 2022.

DPI Research has announced the addition of the "United States Insulin Pump Market & Forecast to 2022" report to its offering http://www.dpiresearch.com/report-details.php?P_ID=96

High Intensity Focused Ultrasound (HIFU) System Market & Opportunities to 2022

DPI Research has announced the addition of the "High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022" report to its offering